高级别肾损伤延迟期CT:干预增加但结局未改善及随访症状的预测价值
这项单中心回顾性队列研究分析了2013至2023年收治的234例美国创伤外科协会分级III至V级肾损伤患者(18至89岁),其中101例(43.2%)在住院期间接受了延迟期CT。延迟期CT组泌尿外科干预率高于无延迟期CT组(21.8% vs 2.3%,p<0.001),但主要并发症率相似(16.8% vs 16.5%,p=0.95)。多变量回归显示延迟期CT与主要并发症无关(OR 1.49,p=0.33),但与泌尿外科干预几率增加相关(OR 15.22,p<0.001)。随访延迟期CT时至少存在一种症状(白细胞增多、发热、腰痛、血尿)对尿外渗的敏感性和阴性预测值均为100%(p=0.019),所有无症状患者随访延迟期CT均为阴性。作者认为结果提示泌尿外科干预和随访影像可能存在过度治疗,但鉴于单中心回顾性局限,需进一步前瞻性研究确认。
要点
- 高级别肾损伤患者中,延迟期CT与泌尿外科干预几率增加独立相关(OR 15.22,p<0.001),但与主要并发症无关(OR 1.49,p=0.33)。
- 延迟期CT组泌尿外科干预率21.8% vs 无延迟期CT组2.3%(p<0.001),主要并发症率16.8% vs 16.5%(p=0.95),无显著差异。
- 随访延迟期CT时至少存在一种症状(白细胞增多、发热、腰痛、血尿)对尿外渗的敏感性100%、阴性预测值100%(p=0.019)。
- 所有无症状患者随访延迟期CT均为阴性。
- 作者认为结果提示泌尿外科干预和随访影像可能存在过度治疗,但需进一步前瞻性研究确认。
适用人群与场景
- 18至89岁、美国创伤外科协会(AAST)肾损伤分级III至V级的患者,来自一家一级创伤中心2013至2023年的收治人群。
研究设计与关键结果
- 回顾性队列研究,纳入234例AAST III至V级肾损伤患者(18至89岁),单中心,2013至2023年;101例(43.2%)住院期间接受延迟期CT。
- 延迟期CT组与无延迟期CT组基线特征相似,包括损伤分级(p=0.13)。
- 延迟期CT组泌尿外科干预率21.8% vs 无延迟期CT组2.3%(p<0.001);主要并发症率16.8% vs 16.5%(p=0.95),无显著差异。
- 多变量回归:延迟期CT与主要并发症无关(OR 1.49,p=0.33),与泌尿外科干预几率增加相关(OR 15.22,p<0.001)。
- 随访延迟期CT亚组分析:至少存在一种症状(白细胞增多、发热、腰痛、血尿)对尿外渗的敏感性100%、阴性预测值100%(p=0.019);所有无症状患者随访延迟期CT均为阴性。
证据类型、等级与局限
- 证据类型:回顾性队列研究;证据等级:治疗/临床管理,Level IV。
- 局限:单中心回顾性研究;作者指出需进一步前瞻性研究确认。
对床旁实践的改变
- 作者认为,延迟期CT与泌尿外科干预增加相关但未改善主要并发症,提示泌尿外科干预和随访影像可能存在过度治疗。
- 随访延迟期CT时,至少存在一种症状(白细胞增多、发热、腰痛、血尿)对尿外渗的敏感性和阴性预测值均为100%,所有无症状患者随访延迟期CT均为阴性。
- 作者指出,鉴于单中心回顾性局限,需进一步前瞻性研究确认。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Screening for urinary extravasation after high-grade renal trauma using delayed-phase computed tomography (DPCT) has been associated with increased urological intervention rates. We investigated the association of DPCT with urological intervention and major complication rates while analyzing the predictive value of clinical symptoms of urinary extravasation at follow-up DPCT.
METHODS: This retrospective cohort study analyzed patients aged 18 to 89 years with American Association for the Surgery of Trauma grades III to V renal injuries at a level 1 trauma center from 2013 to 2023. Data were obtained from the institutional trauma registry and electronic medical records. Univariable and multivariable regressions assessed the association of DPCT with major complication and urological intervention rates. In a subgroup analysis of only follow-up DPCT, the sensitivity, specificity, positive predictive value, and negative predictive value of urinary extravasation signs and symptoms (leukocytosis, fever, flank pain, hematuria) were calculated.
RESULTS: Of 234 patients, 101 (43.2%) underwent DPCT at any point during their hospital course. Baseline characteristics were similar between DPCT versus no DPCT, including injury grade (p = 0.13). Delayed-phase CT patients had higher rates of urological interventions compared with no DPCT (21.8% vs. 2.3%, p < 0.001) but similar complication rates (16.8% vs. 16.5%, p = 0.95). After multivariable regression, DPCT was not associated with major complications (odds ratio, 1.49; p = 0.33) but with increased odds of undergoing urological intervention (odds ratio, 15.22; p < 0.001). The presence of at least one symptom at follow-up DPCT had a sensitivity and NPV of 100% for urinary extravasation (p = 0.019).
CONCLUSION: Delayed-phase CT was strongly associated with urological interventions for urinary extravasation but not associated with major complications after risk adjusted analyses, and all asymptomatic patients had negative follow-up DPCTs. While our results suggest potential overtreatment regarding urological interventions and follow-up imaging, further confirmative prospective studies are needed given our study's single-center retrospective limitations.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Rice W, Mancoll R, Harper S, et al. Delayed-phase computed tomography in high-grade renal trauma: Increased interventions without improved outcomes and the predictive value of symptoms at follow-up. J Trauma Acute Care Surg. 2026. PMID: 41589735. doi:10.1097/TA.0000000000004825
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。